ALKBH1 is a 2-oxoglutarate-and Fe 2+ -dependent dioxygenase responsible for multiple cellular functions. Here, we show that ALKBH1 is involved in biogenesis of 5-hydroxymethyl-2 -O-methylcytidine (hm 5
INTRODUCTION
Cellular RNAs contain numerous chemical modifications that are introduced enzymatically after transcription. More than 130 types of modified nucleosides have been reported in various RNA molecules from all domains of life (1) , of which about 80% of them were found in tRNAs. tRNA modifications ensure proper tRNA function of tRNAs by stabilizing tertiary structure, and fine-tuning decoding properties for translation (2) . A wide variety of RNA modifications are present at the first position (wobble position or position 34) of tRNA anticodons. These modifications play pivotal roles in accurate and efficient translation by modulating codon-anticodon interaction at the ribosomal A-site (3).
5-Formylcytidine (f 5 C) ( Figure 1A ), first discovered in mammalian mitochondrial (mt) tRNA ( Figure 1B ) (4) , is a unique modification found at position 34 of mt-tRNAs Met from vertebrates and nematodes (4) (5) (6) . In mammalian mitochondria, the AUA codon specifies Met instead of Ile (7) . In vitro translation revealed that f 5 C34 enables mt-tRNA Met to recognize AUA as well as AUG (8) . Because the sole mt-tRNA Met acts in both initiation and elongation in mitochondrial protein synthesis, f 5 C34 is an essential modification for mitochondrial protein synthesis. A structural study of the codon-anticodon interaction at the ribosomal A-site revealed that f 5 C34 pairs with adenosine at the third letter of the AUA codon in a canonical Watson-Crick geometry, implying that f 5 C undergoes imino-oxo tautomerization to pair with AUA (9) . Since the discovery of this modification, however, biogenesis and physiological role of f 5 C34 remained unresolved. Last year, we demonstrated that biogenesis of f 5 C34 is initiated by S-adenosylmethionine (AdoMet)-dependent methylation catalyzed by NSUN3 (6) . Knockout (KO) of NSUN3 resulted in severe reduction in mitochondrial protein synthesis and respiratory activity, leading to mitochondrial dysfunction. We successfully reconstituted formation of 5-methylcytidine (m 5 C) at the wobble position of mt-tRNA Met with recombinant NSUN3 in the presence of AdoMet, suggesting that f 5 C34 is synthesized by NSUN3-mediated m 5 C34 formation, followed by hydroxylation and oxidation of the methyl group.
We identified two pathogenic point mutations (A4435G and C4437U) in mt-tRNA Met ( Figure 1B ) that impaired m 5 C34 formation by NSUN3 (6) . These mutations are associated with mitochondrial diseases presenting with maternally inherited hypertension, Leber's hereditary optic neuropathy, hypotonia, seizure, muscle weakness, lactic acidosis and hearing loss (10) (11) (12) . In addition, a loss-of-function mutation in NSUN3 was identified in a patient presenting with symptoms of mitochondrial disorder, including devel- (41, 67) . Eight pathogenic point mutations are indicated in human mt-tRNA Met . opmental disability, microcephaly, muscular weakness, external ophthalmoplegia and lactic acidosis (13, 14) . These observations indicated that loss of f 5 C34 or NSUN3 results in pathological consequence.
In a previous study, ALKBH1 could oxidize m 5 C34 in the anticodon-stem loop of mt-tRNA Met to form f 5 C34 in vitro (15) , although hm 5 C34 was not detected. Indirect detection of f 5 C34 using chemical derivatization combined with primer extension revealed that the fraction of f 5 C34-containing mt-tRNA Met decreased upon ALKBH1 knockdown, indicating that ALKBH1 is involved in f 5 C34 formation. However, hm 5 C34 and m 5 C34 could not be distinguished in this experiment, and it remained unclear to what extent ALKBH1 contributes to this process in the cell. Considering that ALKBH1 is involved in demethylation of N 6 -methyldeoxyadenosine (m 6 dA) in genomic DNA (16) and demethylation of 1-methyladenosine (m 1 A) in cytoplasmic (ct-)tRNAs (17) , it was necessary to perform a more sophisticated analysis of the modification status of tRNAs with the goal of obtaining direct evidence for ALKBH1 as an RNA oxygenase responsible for f 5 C34 formation. On the other hand, 2 -O-methyl derivative of f 5 C (5-formyl-2 -O-methylcytidine, f 5 Cm) ( Figure 1A ) is present at the wobble position of mammalian ct-tRNA Leu with the CAA anticodon ( Figure 1B) (18) . Given that f 5 C allows tRNA to pair with A (8), this modification has been speculated to permit the recognition of UUA in addition to UUG. Notably, the 5-hydroxymethylcytidine derivative hm 5 Cm ( Figure 1A ), a reduced form of f 5 Cm, has also been detected in this tRNA (18) , strongly indicating that f 5 Cm and hm 5 Cm are synthesized via oxidation of m 5 C. A metabolic labeling study revealed that hm 5 C and f 5 C in mouse total RNA are generated by oxidation of m 5 C (19), indicating that hm 5 Cm and f 5 Cm in ct-tRNA Leu (CAA) are synthesized by hydroxylation and oxidation of m 5 C. However, the RNA dioxygenase responsible for this process has not been previously identified.
Here, we report that ALKBH1 is an RNA dioxygenase involved in biogenesis of hm 5 Cm34 and f 5 Cm34 in ct-tRNA Leu , as well as f 5 C34 in mt-tRNA Met , ALKBH1-knockout cells exhibited a strong reduction in mitochondrial translation and reduced oxygen consumption, indicating that ALKBH1 is required for efficient mitochondrial activity. We successfully reconstituted formation of hm 5 C and f 5 C with ALKBH1 in the presence of 2-oxoglutarate (2-OG) and Fe 2+ , demonstrating that f 5 C is synthesized by Nucleic Acids Research, 2017, Vol. 45, No. 12 7403 consecutive hydroxylation and oxidation of m 5 C. We also examined several pathogenic mutations in mt-tRNA Met associated with mitochondrial diseases, but these mutations had little effect on f 5 C formation mediated by ALKBH1, indicating that these diseases are caused by lack of f 5 C in the mutant tRNAs resulting from defective methylation by NSUN3, but not from defective oxidation by ALKBH1. Moreover, we found that the frequency of m 1 A in two mt-tRNAs increased in ALKBH1 KO cells, indicating that ALKBH1 also has demethylation activity toward m 1 A in some mt-tRNAs.
MATERIALS AND METHODS

Cell culture and measurement of cell proliferation
HEK293T cells were cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillinstreptomycin at 37
• C under a humidified atmosphere containing 5% CO 2 . ALKBH1 KO and NSUN3 KO HEK293T cells were cultured in DMEM (high-glucose) supplemented with 10% FBS, 1% penicillin-streptomycin, 0.11 g/l sodium pyruvate and 0.05 g/l uridine. For measuring cell proliferation, wild-type (WT) and KO HEK293T cells were seeded on 96-well plates (8.0 × 10 3 cells per well) in glucose medium (no-glucose DMEM supplemented with 2 mg/ml glucose) or galactose medium (no-glucose DMEM supplemented with 2 mg/ml galactose) supplemented with alamarBlue reagent (Invitrogen). The plates were incubated at 37
• C for 3 h, and the absorbances at 570 and 600 nm were measured on a SpectraMax 190 microplate reader (Molecular Devices). Cell proliferation was evaluated based on the percentage of reduced dye.
Construction of ALKBH1 KO lines
The human ALKBH1 gene was knocked out using the CRISPR-Cas9 system basically as described (20) . We designed an sgRNA targeting exon 4 of ALKBH1 gene. Sense and antisense DNAs for the sgRNA (Supplementary Table S1) were cloned into vector pX330 (Addgene plasmid 42230). HEK293T cells (2.0 × 10 5 cells per well) were transfected with the cloned vector (300 ng) and seeded on 24-well plates. The KO efficiency of each sgRNA was evaluated by surveyor assay using a specific pair of primers (Supplementary Table S1 ). The cells were diluted and sub-cultured on 10 cm dishes. Eleven days after the transfection, colonies were isolated and genomic DNAs were extracted. ALKBH1 KO lines were selected by confirming the frameshift mutations in the target region.
RNA extraction and tRNA isolation
Total RNA was extracted from HEK293T cells using TriPure Isolation Reagent (Roche Life Science). Total RNA from mouse fetus was kindly provided by S. Nakagawa (Hokkaido University). Individual tRNAs were isolated by reciprocal circulating chromatography (RCC) (21, 22) using the 5 -terminal ethylcarbamate amino-modified DNA probes listed in Supplementary Table S1 .
RNA mass spectrometry
Isolated tRNA (1-2 pmol) was digested with RNase T 1 , RNase A or MazF (Takara Bio.) at 37
• C for 30 min in 20 mM NH 4 OAc (pH 5.3), followed by mixing with an equal volume of 100 mM triethylamine-acetate and subjected to capillary liquid chromatography (LC)-nano-electrospray ionization (ESI)-mass spectrometry (MS) as described (22) (23) (24) .
cDNA cloning and expression of recombinant ALKBH1
The cDNA of human ALKBH1 (GenBank NM 006020.2) was obtained by nested polymerase chain reaction from total RNA of HEK293T cells using specific primers (Supplementary Table S1 ) and cloned into pE-SUMO-NSUN3 (6) using the In-Fusion HD cloning kit (Clontech) to yield pE-SUMO-ALKBH1. Escherichia coli Rosetta2 (DE3) (Novagen) was transformed with pE-SUMO-ALKBH1 and cultured at 25
• C. When the OD 600 reached 0.4, 10 M Isopropyl ␤-D-1-thiogalactopyranoside (IPTG) was added, and the culture was incubated at 16
• C for an additional 24 h. The harvested cells were lysed by sonication in a buffer consisting of 20 mM Tris-HCl (pH 7.5), 0.5 M KCl, 1 mM dithiothreitol (DTT) and 0.5 mM phenylmethanesulfonyl fluoride (PMSF). Soluble protein was loaded onto a HisTrap HP column (GE Healthcare) on an AKTA Purifier 10 system (GE Healthcare) and separated with 0-500 mM gradient of imidazole. Fractions containing His6-SUMO-tagged human ALKBH1 were collected and dialyzed overnight in buffer consisting of 20 mM Tris-HCl (pH 7.5), 0.5 M KCl, 1 mM DTT and 10% glycerol. The His6-SUMO tag was cleaved by ubiquitin-like specific protease 1 (Ulp1) at 4
• C overnight, and then removed by passing the sample through HisLink protein proliferation resin (Promega). The untagged protein was equilibrated with a buffer consisting of 50 mM Tris-HCl (pH 8.0), 50 mM NaCl and 7 mM 2-mercaptoethanol, and further purified by Mono Q anion exchange chromatography (HR 5/5, GE Healthcare) with a gradient of NaCl (50-1000 mM) using AKTA Purifier 10 system (GE Healthcare). The purified ALKBH1 was dialyzed against a buffer consisting of 50 mM Tris-HCl (pH 8.0), 100 mM NaCl and 7 mM 2-mercaptoethanol, followed by addition of glycerol to 30% f.c.
In vitro reconstitution of f 5 C34 by recombinant ALKBH1
WT and mutant mt-tRNAs Met were prepared by in vitro transcription using T7 RNA polymerase, basically as described (25 (Figure 6C ) and subjected to LC/MS as described above.
Mitochondrial activities
HEK293T WT, ALKBH1 KO and NSUN3 KO cells (4.0 × 10 7 ) were suspended in 3 ml MOPS buffer consisting of 10 mM MOPS, 250 mM sucrose and 1 × Complete Mini Protease Inhibitor Cocktail Tablet (Roche), and then homogenized on ice by 12 up-and-down strokes with a Teflon homogenizer. The homogenate was centrifuged at 600 × g for 5 min at 4
• C, and the supernatant was further centrifuged at 10 000 × g for 15 min at 4
• C. The mitochondrial pellet was collected and resuspended in MOPS buffer. The activities of respiratory chain complexes were evaluated as described (26) . The oxygen consumption rate (OCR) of WT, ALKBH1 KO and NSUN3 KO cells was measured using an XF24-3 extracellular flux analyzer (Seahorse Bioscience).
Pulse labeling of mitochondrial protein synthesis
HEK293T WT, ALKBH1 KO and NSUN3 KO cells (2.0 × 10 4 ) were seeded on 10 cm dishes and cultured overnight. Cells were washed with L-Met-, L-Gln-and L-Cys-free medium (Sigma-Aldrich) supplemented with 2 mM L-Gln, 10% FBS and 1 mM sodium pyruvate. To inhibit cytoplasmic protein synthesis, 50 g/ml emetine was added to the medium and incubated for 10 min. The cells were further supplemented with 8. 
]-, PerkinElmer) and incubated for 1 h to label proteins translated in mitochondria. Then, the medium was replaced with cold medium (DMEM with 10% FBS) and chased for 10 min, and the cells were harvested by centrifugation at 1500 × g for 10 min at 4
• C. The cell lysates were resolved by Tricine-sodium dodecylsulphatepolyacrylamide gel electrophoresis (SDS-PAGE) (16.5%), and the gel was coomassie brilliant blue (CBB)-stained and dried by a gel drier (AE-3750 RapiDry, ATTO). The dried gel was exposed to an imaging plate (BAS-MS2040, Fujifilm) and visualized on a FLA-7000 fluorimager (Fujifilm).
Primer extension to detect m 1 A modification
Primer extension was conducted basically as described (27, 28) . The 5 32 P-labeled primer (0.1 pmol) was incubated Lys ; dTTP, dGTP and ddATP for mt-tRNA Arg ; and dATP, dTTP, dCTP and ddGTP for mitochondrial 16S rRNA. The reaction was carried out for 1 h at 47
• C for mt-tRNAs and 55
• C for mitochondrial 16S rRNA. The reaction was stopped by addition of 0.5 l of 4 M NaOH and boiling for 5 min at 95
• C, and then neutralized by addition of 4.5 l of 1 M Tris-HCl (pH 5.0). The cDNAs were resolved by 20% denaturing PAGE. The gel was exposed to an imaging plate (BAS-MS2040, Fujifilm) and visualized on a FLA-7000 fluorimager (Fujifilm) .
RESULTS
Modification status of precursors and mature ct-tRNA
Leu (CAA)
In Saccharomyces cerevisiae and vertebrates, cttRNA Leu (CAA) has an intron in its anticodon region (29, 30) , indicating that biogenesis of f 5 Cm34 is coupled with intron removal via tRNA splicing. To study the biogenesis of f 5 Cm34 in ct-tRNA Leu (CAA), we first analyzed the modification status of their precursors by massspectrometric analysis (RNA-MS) and observed sequential formation of f 5 Cm34. From mouse fetus, we isolated two precursors of ct-tRNA Leu (CAA), along with its mature form by RCC (Figure 2A ) (21) . The isolated tRNAs were digested by RNase T 1 and subjected to RNA-MS to detect the anticodon-containing fragments ( Figure 2B ), which were then further probed by collision-induced dissociation (CID) to map the modified residues (Supplementary Figure S1) . The primary transcript of ct-tRNA Leu the nucleus because the post-spliced precursor that had not yet undergone end-maturation already contained hm 5 C34 and f 5 C34 ( Figure 2B ). We chose ALKBH1 as a candidate for the RNA dioxygenase responsible for this process based on its previously reported nuclear functions (16, 33) . We knocked out this gene in HEK293T cells using the CRISPR-Cas9 system and obtained two KO cell lines in which both alleles contained frameshift mutations ( Figure 3A) . Next, we isolated ct-tRNA Leu (CAA) from ALKBH1 KO cells and subjected it to RNA-MS to analyze its modification status ( Figure 3B ). In WT HEK293T cells, f 5 Cm34 and hm 5 Cm34 were abundantly detected in ct-tRNA Leu (CAA). In ALKBH1 KO cells, neither f 5 Cm34 nor hm 5 Cm34 were present, and instead m 5 Cm34 was found, demonstrating that ALKBH1 is responsible for conversion from m 5 Cm34 to f 5 Cm34/hm 5 Cm34. Next, we selected FTSJ1 as a strong candidate for the tRNA methyltransferase responsible for 2 -O-methylation of f 5 Cm34/hm 5 Cm34, because FTSJ1 is localized in the cytoplasm and is involved in 2 -O-methylation of residues at positions 32 and 34 in the anticodon region (34, 35) . We knocked out this gene and obtained a FTSJ1 KO cell line ( Figure 3C ). Ct-tRNA Leu (CAA) was isolated from the KO cells and subjected to RNA-MS. As expected, both the f 5 Cm34 and hm 5 Cm34 detected in WT cells disappeared, and f 5 C34 and hm 5 C34 increased, in FTSJ1 KO cells (Figure 3D Figure 3E ). Taken together, these results elucidate the biogenesis of hm 5 Cm34 and f 5 Cm34 in ct-tRNA Leu (CAA) ( Figure 3E ). First, NSUN2 methylates C34 to give m 5 C34 in the primary transcript of ct-tRNA Leu (CAA) in the nucleus (32), followed by tRNA splicing to remove the intron in the anticodon loop. Then, m 5 C34 in the post-spliced tRNA precursor is partially hydroxylated to form hm 5 C34 and further oxidized to form f 5 C34. During this process, the 5 leader and 3 trailer of the precursor are removed to become an end-matured precursor, which is then exported to the cytoplasm, where the wobble bases are 2 -O-methylated by FTSJ1 together with a partner protein (probably WDR6) to form hm Figure 4A ), albeit partially, probably due to inefficient transfection.
Based on these findings, we propose a reaction scheme for biogenesis of f 5 C34 in mt-tRNA Met ( Figure 4B ). In this pathway, NSUN3 initiates formation of f 5 C34 in mttRNA
Met by AdoMet-dependent methylation of C34 to form m 5 C34. Then, ALKBH1 hydroxylates m 5 C34 to form hm 5 C34, followed by oxidation of hm 5 C34 to yield f 5 C34.
Deletion of ALKBH1 causes mitochondrial dysfunction
Because loss of f 5 C in NSUN3 KO cells results in mitochondrial dysfunction (6), we next examined the growth properties of ALKBH1 KO cells in glucose and galactose media ( Figure 5A ). Mitochondrial activity is required for growth in a medium containing galactose as the primary carbon source (38) . ALKBH1 KO cells grew as well as NSUN3 KO cells in glucose medium, but a bit slower than WT cells. Compared to WT cells, ALKBH1 KO cells grew much more slowly in galactose medium, as also observed for NSUN3 KO cells, indicating that ALKBH1 is required for efficient mitochondrial activity. Next, we biochemically compared respiratory complex activities between ALKBH1 KO, NSUN3 KO and WT cells ( Figure 5B ). We observed a clear reduction of Complex I activity in ALKBH1 KO and NSUN3 KO cells, but no significant changes in the other complexes. The OCRs of ALKBH1 KO and NSUN3 KO cells were substantially lower than that of WT cells ( Figure  5C ), indicating that oxidative phosphorylation and respiratory activity of mitochondria were impaired by ALKBH1 KO.
To examine mitochondrial protein synthesis, we conducted a pulse-labeling experiment in ALKBH1 KO and NSUN3 KO cells ( Figure 5D ). In cells treated with emetine to inhibit cytoplasmic translation, mitochondrial translation was specifically labeled by addition of [ 35 
In vitro reconstitution of f 5 C modification
To examine the enzymatic activity of ALKBH1 responsible for f 5 C formation, we performed in vitro reconstitution of f 5 C34 in mt-tRNA Met . For this purpose, in vitro transcribed mt-tRNA Met containing m 5 C34 introduced by NSUN3 was incubated with recombinant ALKBH1 in the presence or absence of 2-OG and Fe 2+ . The products were digested with RNase T 1 and subjected to RNA-MS ( Figure 6A ). We detected an f 5 C34-containing fragment, along with a hm 5 C34-containing fragment, only in the presence of both 2-OG and Fe 2+ . These modified fragments were further probed by CID to confirm the presence of hm 5 C and f 5 C at position 34 ( Figure 6B ). In addition, we used the m 5 C34-containing anticodon stem-loop (ASL) as a substrate ( Figure 6A ) and found that f 5 C34 and hm 5 C34 were clearly formed in this substrate. We also performed in vitro formation of f 5 C34 from C34 via consecutive reactions mediated by NSUN3 and ALKBH1 ( Figure 6C ). In this experiment, unmodified mt-tRNA Met was incubated with NSUN3 and ALKBH1 in the presence of AdoMet, 2-OG and Fe 2+ . During accumulation of m 5 C34, hm 5 C34 and f 5 C34 gradually formed. Ultimately, 95% of tRNAs were methylated by NSUN3 after 2 h. Among the products, 74% contained hm 5 C34, while 23% had f 5 C34. This finding demonstrated that f 5 C34 can be reconstituted by cooperative modifications with NSUN3 and ALKBH1.
These results suggest that ALKBH1 is a 2-OG-and Fe 2+ -dependent RNA dioxygenase that hydroxylates and oxidizes m 5 C34 to form hm 5 C34 and f 5 C34, respectively. Because ASL could be a substrate for f 5 C34/hm 5 C34 formation, ALKBH1 recognizes the anticodon-stem-loop region and does not require the entire tRNA structure for this reaction. 
Impact of pathogenic point mutations on f 5 C formation
According to MITOMAP, eight point mutations in the mttRNA Met gene are associated with human diseases (39). We previously reported two pathogenic mutations, A4435G and C4437U, that impaired m 5 C34 formation by NSUN3, possibly causing hypomodification of f 5 C34 (6). To determine whether these point mutations affect f 5 C34 formation mediated by ALKBH1, mutant mt-tRNAs Met containing each of eight pathogenic mutations were prepared and methylated by NSUN3 to introduce as much m 5 C34 as possible. Then, we examined in vitro hydroxylation and oxidation of m 5 C34 in these mutant tRNAs by ALKBH1, but observed no obvious reduction of hm 5 C34/f 5 C34 formation ( Figure 6D ). This result suggests that none of the pathogenic point mutations in mt-tRNA Met tested here impair hydroxylation or oxidation of m 5 C34 mediated by ALKBH1.
ALKBH1 is involved in demethylation of m 1 A in mt-tRNAs
ALKBH1 can demethylate m 1 A in ct-tRNAs (17) . Given that ALKBH1 is localized in mitochondria (37), we asked whether mitochondrial ALKBH1 is also involved in demethylation of m 1 A in mitochondrial RNAs. m 1 A is present at positions 9, 16 and 58 of several tRNAs (7, 40, 41) and at position 947 of 16S rRNA (28) . We isolated mt-tRNAs for Arg, Lys and Leu(UUR) from WT and ALKBH1 KO cells, and compared the m 1 A frequencies among them by measuring m 1 A-containing fragments by RNA-MS ( Figure 7AB and Supplementary Figure S2A-C) . The frequency of m 1 A16 in mt-tRNA Arg was higher in ALKBH1 KO cells (33.3%), than in WT cells (17.9%) ( Figure 7A ). The level of m 1 A58 in mt-tRNA Lys was also elevated in ALKBH1 KO cells ( Figure 7B ). The increase in m 1 A frequency at these sites in ALKBH1 KO cells was also confirmed by primer extension (Figure 7CD) . Other m 1 A sites at positions 9 and 58 of mttRNAs were unchanged upon KO of ALKBH1 (Supplementary Figure S2A-C) . In particular, m 1 A58 was fully Figure 1B . Methylation data were obtained from our previous study (6) . Each mt-tRNA Met mutant containing m 5 C34 was incubated with ALKBH1 in the presence of 2-OG and Fe 2+ , followed by RNase T 1 digestion and subjected to RNA-MS. Reaction efficiency was calculated by summing the peak heights of the anticodon-containing fragments bearing hm 5 C34 and f 5 C34, normalized against the total peak heights of the three fragments (m 5 C34, hm 5 C34 and f 5 C34). Frequency of hm 5 C was calculated by subtracting the theoretical value of the second isotopic peak (+2) of the f 5 C-containing fragment. Data are presented as means ± SD of three independent reactions. *P < 0.001, Student's t-test. Figure S2C-F) . Thus, ALKBH1 is not involved in demethylation of m 1 A58 in these tRNAs. We also compared m 1 A frequency at position 947 in 16S rRNA by primer extension analysis and found no significant change in the m 1 A947 level between WT and ALKBH1 KO cells (Supplementary Figure S2G) .
DISCUSSION
Bacterial AlkB is a 2-OG-and Fe 2+ -dependent dioxygenase that repairs alkylation damage, including m 1 A and m 3 C in DNA and RNA (42, 43) . In mammals, nine members of AlkB-family proteins (ALKBH1-8 and fat mass and obesity-associated protein (FTO)) have been identified (44) (45) (46) (47) , of which four are associated with RNA metabolism. FTO is the first RNA dioxygenase shown to have an 'eraser' function involved in demethylation of m 6 A in mRNA in the cell (48) , raising the possibility that m 6 A is reversible. Recent work showed that FTO has a strong demethylation activity for m 6 Am at the 5 termini of capped mRNAs (49) . ALKBH5 is another eraser for m 6 A in mRNA (50) . ALKBH8, a unique protein containing an AlkB domain fused to a tRNA methyltransferase domain, is involved in biogenesis of 5-methoxycarbonylhydroxymethyluridine (mchm 5 U34) at the wobble position of ct-tRNAs (51, 52) . ALKBH3 has demethylation activity toward internal m 1 A in mRNA (53, 54) , and recent work showed that ALKBH3 can demethylate m 6 A in tRNAs (55) , though exact position of m 6 A in tRNA has not been determined yet. ALKBH1, the first mammalian homolog of E. coli AlkB to be identified (44) , is widely conserved among vertebrates and arthropods. ALKBH1 has demethylation activity toward m 3 C in single-stranded DNA and RNA in vitro (37) . ALKBH1 was once proposed to regulate neurodevelopment by demethylating histone H2A (33); however, this demethylation activity was not confirmed (16) . Instead, it was proposed that ALKBH1 has the ability to demethylate m 6 dA in DNA (16) . A study published last year showed that ALKBH1 has a role in demethylating m 1 A58 in cttRNAs (17) , thus regulating protein synthesis by downregulating translation initiation and decreasing participation of tRNAs in the elongation stage. The physiological role of ALKBH1 has been inferred based on phenotypic features of Alkbh1-null mice. A mouse harboring a deletion of exon 3 exhibited intra-uterine growth retardation with defective placenta (56) . By contrast, the exon 6 deletion mouse exhibited non-Mendelian inheritance of the targeted Alkbh1 allele and sex-ratio distortion of the offspring (57), indicating that ALKBH1 plays critical roles in the early development. Our finding of ALKBH1 as an RNA dioxygenase responsible for f 5 C formation in cytoplasmic and mitochondrial tRNAs might provide insight into the enzyme's physiological role in mammals.
In this study, we showed that human ALKBH1 catalyzes hydroxylation and oxidization of m 5 C34 in both ct-tRNA Leu Met from HEK293T and HeLa cells, and directly analyzed anticodon-containing fragments by LC/MS to determine the exact frequency of each modification. We could detect the RNA fragments containing C34, m 5 C34, hm 5 C34,or f 5 C34 separately, based on their exact molecular masses. RNA fragments are ionized by ESI as negative ions derived from phosphate groups. Hence, ionization efficiencies of RNA fragments bearing the same sequences, but different modifications, do not significantly differ in general, because ESI ionization relies mainly on numbers of phosphate groups, rather than the type of base modifications (23) . The relative amounts of these fragments can be calculated by their detection intensities. Using this method, we demonstrated that mt-tRNA Met is fully modified with f 5 C34 in both HEK293T ( Figure 4A ) and HeLa cells (Supplementary Figure S3 ). No hypomodified fragment bearing C34, m 5 C34 or hm 5 C34 was detected in mature mt-tRNA Met , which participates in translation. However, we cannot rule out the possibility that f 5 C34 is dynamically regulated in different tissues and cells via alternative expression of NSUN3 and ALKBH1, or due to an intracellular change in concentrations of AdoMet, Fe 2+ , 2-OG and O 2 . In vitro reconstitution of f 5 C34 revealed that ALKBH1 catalyzes hydroxylation and oxidation of m 5 C34 in the presence of 2-OG and Fe 2+ ( Figure 6A ). In addition, we successfully reconstituted f 5 C34 from C34 by consecutive reactions catalyzed by NSUN3 and ALKBH1. Over the course of these reactions, m 5 C34 was formed rapidly, followed by the appearance of hm 5 C34 and ultimately f 5 C34 gradually accumulated, but no 5-carboxycytidine (ca 5 C34) was formed. This reaction profile indicates that ALKBH1 catalyzes twostep reactions initiated by hydroxylation of m 5 C34 to form (63, 64) . TET enzymes can also oxidize m 5 C in RNA to form hm 5 C in vitro as well as in human culture cells (65) . In Drosophila, hm 5 C in RNA is synthesized by dTet (66), indicating that TET enzymes also participate in the formation of hm 5 C in RNA. However, hm 5 Cm in ct-tRNA Leu (CAA) was completely absent in the ALKBH1 KO cells used in this study, ruling out a possibility that TET enzymes are redundantly involved in this process. Considering that the target sites of ALKBH1 reside in loop regions of RNA hairpins (17) , ALKBH1 might oxidize m 5 C to form hm 5 C or f 5 C in the loop regions of mRNAs.
We also investigated whether ALKBH1 is involved in demethylation of m 1 , these results indicate that ALKBH1 prefers to recognize the stem-loop structure of RNA and oxidize the target methyl group. We previously reported that m 1 A58 in mt-tRNAs is introduced by Trmt61B (27) . However, knockdown of this gene in HeLa cells caused no obvious phenotype. Thus, regulation of m 1 A58 by ALKBH1 might have a moderate effect in mitochondrial function, and the mitochondrial dysfunction observed in ALKBH1 KO cells should be largely attributed to the loss of f 5 C34 in mttRNA Met . In this study, we found that ALKBH1 is responsible for biogenesis of hm 5 Cm34/f 5 Cm34 in ct-tRNA Leu (CAA), as well as f 5 C34 in mt-tRNA Met . ALKBH1 KO cells exhibited strong reduction in mitochondrial translation and reduced respiratory complex activities, demonstrating that ALKBH1-mediated f 5 C34 formation is required for mitochondrial functions. In vitro reconstitution of f 5 C34 revealed that ALKBH1 first hydroxylates m 5 C34 to form hm 5 C34, and then oxidizes hm 5 C34 to form f 5 C34. We also found two m 1 A sites in mt-tRNAs that were present at higher frequencies in ALKBH1 KO cells, indicating that mitochondrial ALKBH1 is also involved in m 1 A demethylation.
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